The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 10th May 2013 07:14

Afren: Westhouse Securities initiates with a target price of 160p and a buy recommendation.Ashmore Group: Credit Suisse raises target price from 375p to 440p upgrading from underperform to neutral.Barratt Developments: Citigroup increases target price from 245p to 315p leaving its neutral rating unchanged. Deutsche Bank shifts target price from 323p to 336p and reiterates a buy recommendation.British Sky Broadcasting Group: Bank of America cuts target price from 670p to 650p and reiterates an underperform rating.Britvic: Deutsche Bank raises target price from 425p to 460p and retains a hold recommendation.BT Group: Bank of America takes target price from 275p to 325p and upgrades to buy.Clarke T: Panmure Gordon moves target price from 40p to 58p and upgrades from hold to buy.Derwent London: Morgan Stanley increases target price from 2220p to 2450p and upgrades to overweight.e-Therapeutics: Panmure Gordon shifts target price from 72p to 67p keeping its buy recommendation.Experian: Citigroup raises target price from 1320p to 1410p and maintains a buy recommendation. Deutsche Bank downgrades to hold with a target price of 529p.Greencore: Investec shifts target price from 125p to 130p and maintains a buy recommendation. Panmure Gordon takes target price from 110p to 125p retaining its buy recommendation.Inchcape: HSBC Holdings initiates with a target price of 640p and an overweight rating.InterContinental Hotels Group: JP Morgan lowers target price from 1950p to 1920p and reiterates a neutral rating.London Mining: JP Morgan moves target price from 215p to 205p and maintains an overweight rating.Lonmin: Exane BNP lowers target price from 270p to 260p staying with its neutral rating.Morrison (Wm): Nomura ups target price from 270p to 310p keeping a neutral rating.National Grid: JP Morgan moves target price from 730p to 785p and retains a neutral rating.Ocado Group: Goldman Sachs upgrades to buy with its target price at 300p. Panmure Gordon raises target price from 50p to 130p, but still recommends selling.Portmeirion: Panmure Gordon takes target price from 657p to 694p reiterating its buy recommendation.Restaurant Group: Panmure Gordon increases target price from 435p to 560p and keeps a buy recommendation.Rightmove: Panmure Gordon ups target price from 2000p to 2300p and leaves its buy recommendation unchanged.RPC Group: JP Morgan reduces target price from 512p to 491p and stays with its overweight rating.Sage Group: Exane BNP shifts target price from 235p to 240p and leaves its underperform rating unaltered.SIG: JP Morgan raises target price from 95p to 135p, while maintaining an underweight rating.St Modwen Properties: JP Morgan increases target price from 290p to 320p staying with its overweight rating.Travis Perkins: JP Morgan ups target price from 999p to 1380p, while its neutral rating remains unchanged. Panmure Gordon downgrades from buy to hold with a target price of 1350p.TUI Travel: Numis ups target price from 350p to 375p and reiterates an add rating. Panmure Gordon moves target price from 303p to 315p, while its hold recommendation is reiterated.Restaurant Group: Citigroup downgrades to neutral with a target price of 500p.Royal Bank of Scotland: Citigroup lowers target price from 300p to 290p keeping a neutral rating.Wetherspoon (JD): Deutsche Bank takes target price from 490p to 520p and maintains a hold recommendation. Panmure Gordon increases target price from 615p to 738p retaining a buy recommendation.
More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.